Prestige Consumer

PRESTIGE CONSUMER HEALTHCARE

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

nike-blazer-low-77

News

Upgrades

Markets

Analyst Ratings

Trading Ideas

This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Earnings

Earnings Misses

MEDP

Prestige Consumer Healthcare Inc. (NYSE: PBH) delivered fourth-quarter fiscal 2024 earnings per share of $1.02, a 4.7% decline from the year-ago period&#39;s figure. The metric also missed the Zacks Consensus Estimate by 10.5%.

Prestige Consumer Q4 Earnings Miss, Operating Margin Falls

Santa,Clara,,Ca, - ,Usa,-,March,26,,2019:,Cisco

Pre-Market Outlook

ARCO

CSCO

DOLE

INFN

Cisco, Prestige Consumer Healthcare And 3 Stocks To Watch Heading Into Wednesday

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer Healthcare Inc

Pathfinder Bancorp Inc

PARAMOUNT BED CO ORD by Paramount Bed Co., Ltd.

Paramount Bed Holdings Co Ltd

PBS Holding Inc

PALIBURG HOLDINGS LTD by PALIBURG HOLDINGS LTD.

Press Releases

Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results

Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference

Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results

Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results

Management

Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco's Role to Include Chief Operating Officer Responsibilities

Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation

Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Intra-Cellular Therapies Inc. - Common Stock

Intra-Cellular Therapies

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Organon

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Prestige Consumer

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga